These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7516575)

  • 21. Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostatic hyperplasia.
    el Din KE; Koch WF; de Wildt MJ; Kiemeney LA; Debruyne FM; de la Rosette JJ
    J Urol; 1996 Jun; 155(6):1959-64. PubMed ID: 8618297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire.
    Lemack GE; Zimmern PE
    Urology; 1999 Sep; 54(3):461-6. PubMed ID: 10475355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of LUTS using bother index in DAN-PSS-1 questionnaire.
    Häkkinen JT; Hakama M; Huhtala H; Shiri R; Auvinen A; Tammela TL; Koskimäki J
    Eur Urol; 2007 Feb; 51(2):473-7; discussion 477-8. PubMed ID: 16879907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The correlation between bladder outlet obstruction and lower urinary tract symptoms as measured by the international prostate symptom score.
    el Din KE; Kiemeney LA; de Wildt MJ; Rosier PF; Debruyne FM; de la Rosette JJ
    J Urol; 1996 Sep; 156(3):1020-5. PubMed ID: 8709300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Validation of the patient-administered Danish Prostate Symptom Score Schedule].
    Hansen BJ; Flyger HL; Brasso K; Schou J; Nordling J; Andersen JT; Mortensen SO; Meyhoff HH; Walter S; Hald T
    Ugeskr Laeger; 1997 Jan; 159(5):591-7. PubMed ID: 9045449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Objective and subjective response criteria to diagnose benign prostatic hyperplasia.
    Roehrborn CG
    Eur Urol; 1993; 24 Suppl 1():2-11. PubMed ID: 7687554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Eckhardt MD; van Venrooij GE; Boon TA
    Urology; 2001 Apr; 57(4):695-700. PubMed ID: 11306383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The urodynamic examination in prostatism].
    Svihra J; Poulsen AL; Schou J
    Rozhl Chir; 1993 Oct; 72(7):307-10. PubMed ID: 7508146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower urinary tract symptoms in young men: videourodynamic findings and correlation with noninvasive measures.
    Nitti VW; Lefkowitz G; Ficazzola M; Dixon CM
    J Urol; 2002 Jul; 168(1):135-8. PubMed ID: 12050507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of invasive urodynamic testing in benign prostatic hyperplasia and male lower urinary tract symptoms.
    Mehdizadeh JL; Leach GE
    Urol Clin North Am; 2009 Nov; 36(4):431-41, v. PubMed ID: 19942043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of patients with bladder outlet obstruction and mild international prostate symptom score followed up by watchful waiting.
    Netto NR; de Lima ML; Netto MR; D'Ancona CA
    Urology; 1999 Feb; 53(2):314-6. PubMed ID: 9933046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men.
    Sarma AV; Jacobsen SJ; Girman CJ; Jacobson DJ; Roberts RO; Rhodes T; Lieber M
    J Urol; 2002 Oct; 168(4 Pt 1):1446-52. PubMed ID: 12352415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and grading of outflow obstruction.
    Khan Z; Mieza M; Bhola A; Starer P
    Urology; 1988 Jul; 32(1):72-7. PubMed ID: 2455375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of intermittency in men with lower urinary tract symptoms.
    Reynard J; Lim C; Abrams P
    Urology; 1996 Apr; 47(4):491-6. PubMed ID: 8638356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptom scores: mumbo jumbo or meaningful measures?
    Stage AC; Hairston JC
    Curr Urol Rep; 2005 Jul; 6(4):251-6. PubMed ID: 15978223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
    Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
    BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The natural history of untreated "prostatism".
    Ball AJ; Feneley RC; Abrams PH
    Br J Urol; 1981 Dec; 53(6):613-6. PubMed ID: 6172172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
    Blaivas JG
    Urology; 1988 Dec; 32(6 Suppl):5-11. PubMed ID: 2462303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
    Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
    J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms.
    Liao CH; Chung SD; Kuo HC
    Int J Clin Pract; 2011 May; 65(5):552-8. PubMed ID: 21489080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.